From genotype to molecular phenotype by proteomics

Cancer systems biology

Global cancer partnership

Improving cancer control in low-middle income countries and creating a global network of expertise

Buparlisib helps overcome endocrine resistance in metastatic breast cancer: BELLE-2 trial results

Survival outcomes from the CALGB 40603 study in triple-negative breast cancer

TH3RESA: T-DM1 improves overall survival in previously treated advanced cancer patients

Molecular evolution of breast cancer during neoadjuvant chemotherapy

NSABP FB-7: Neoadjuvant therapy with neratinib plus trastuzumab in locally advanced HER2-positive breast cancer

HER2 status as predictive marker for aromatase inhibitor versus tamoxifen use in early breast cancer

Trastuzumab emtansine improves overall survival versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cance

Homologous recombination deficiency predicts neo-adjuvant chemotherapy response in triple-negative breast cancer